David Miles
oncology
Bioagri Laboratories
United Arab Emirates
Biography
He advises the National Institute for Health and Clinical Excellence (NICE) on the adoption of new drugs being considered for breast cancer and was a member of the committee invited by NICE to produce guidelines for the treatment of early stage breast cancer. He also sits on the NICE quality standards committee for the treatment of breast cancer. He is currently a module leader and lecturer at the Institute of Cancer Research and frequently lectures internationally. He is an advisor to the charity Breast Cancer Care, a board member of the Cancer Vaccine Institute and sit on the Central Institutional Review Board of Cancer Research UK.
Research Interest
He advises the National Institute for Health and Clinical Excellence (NICE) on the adoption of new drugs being considered for breast cancer and was a member of the committee invited by NICE to produce guidelines for the treatment of early stage breast cancer. He also sits on the NICE quality standards committee for the treatment of breast cancer. He is currently a module leader and lecturer at the Institute of Cancer Research and frequently lectures internationally. He is an advisor to the charity Breast Cancer Care, a board member of the Cancer Vaccine Institute and sit on the Central Institutional Review Board of Cancer Research UK.
